# PK & Tolerability of CNV1014802 in Young and Elderly Healthy Volunteers

> **NCT02359344** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 32 (actual)

## Conditions studied

- Trigeminal Neuralgia

## Interventions

- **DRUG:** CNV1014802
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02359344
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-03
- **Primary completion:** 2015-04-20
- **Final completion:** 2015-04-20
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2017-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02359344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02359344, "PK & Tolerability of CNV1014802 in Young and Elderly Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02359344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*